Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Urothelial Cancer/Enfortumab Vedotin

Petros Grivas

MD, PhD

🏢University of Washington / Fred Hutchinson Cancer Center🌐USA

Professor of Medicine

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Petros Grivas is a prominent genitourinary oncologist advancing antibody-drug conjugate and immunotherapy strategies for urothelial cancer. He has been a key investigator in enfortumab vedotin clinical trials and leads biomarker-driven research to optimize patient selection. His translational work on Nectin-4 and other ADC targets has expanded therapeutic options.

Share:

🧪Research Fields 研究领域

Urothelial cancer
Enfortumab vedotin
Biomarker research
ADC therapy
GU oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Petros Grivas 的研究动态

Follow Petros Grivas's research updates

留下邮箱,当我们发布与 Petros Grivas(University of Washington / Fred Hutchinson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment